Year ended 31 March 2025 £000 | Year ended 31 March 2024 £000 | |
Dividends from unquoted companies | – | 323 |
Dividends from quoted companies | – | 72 |
Money market funds* | 1,783 | 1,499 |
Bank deposits* | 347 | 445 |
Loans to unquoted companies | 1,014 | 382 |
Listed interest-bearing investments | – | 17 |
3,144 | 2,738 |
Year ended 31 March 2025 | Year ended 31 March 2024 | |||||
Revenue £000 | Capital £000 | Total £000 | Revenue £000 | Capital £000 | Total £000 | |
Basic investment management fee | 567 | 1,701 | 2,268 | 515 | 1,545 | 2,060 |
Performance-related fee | – | 321 | 321 | – | – | – |
567 | 2,022 | 2,589 | 515 | 1,545 | 2,060 |
Year ended 31 March 2025 £000 | Year ended 31 March 2024 £000 | |
Administrative and secretarial services | 79 | 76 |
Directors’ remuneration | 140 | 114 |
National Insurance contributions | 15 | 16 |
Auditor’s remuneration – audit services | 76 | 63 |
– non-audit services | – | – |
Legal and professional expenses | 106 | 59 |
Share issue promoter’s commission | 33 | 40 |
Other expenses | 226 | 234 |
675 | 602 |
Year ended | Year ended | |||||
31 March 2025 | 31 March 2024 | |||||
Revenue £000 | Capital £000 | Total £000 | Revenue £000 | Capital £000 | Total £000 | |
(a) Analysis of charge / (credit) for the year | ||||||
UK corporation tax payable / (recoverable) on the return for the year | 852 | (852) | – | (73) | 73 | – |
(b) Tax reconciliation | ||||||
Return before tax | 1,902 | 6,464 | 8,366 | 1,621 | 1,227 | 2,848 |
Return multiplied by the standard rate of UK corporation tax of 25.0% (2024: 25.0%) | 476 | 1,616 | 2,092 | 405 | 307 | 712 |
Effect of: | ||||||
Dividends not subject to tax | – | – | – | (478) | – | (478) |
Capital returns not subject to tax | – | (787) | (787) | – | (233) | (233) |
Movements in fair value of investments not subject to tax | – | (1,335) | (1,335) | – | (460) | (460) |
Increase in surplus management expenses | – | 30 | 30 | – | 459 | 459 |
Adjustment in respect of previous year | 376 | (376) | – | – | – | – |
Tax (credit) / charge for the year | 852 | (852) | – | (73) | 73 | – |
Year ended 31 March 2025 | Year ended 31 March 2024 | |||||
Revenue £000 | Capital £000 | Total £000 | Revenue £000 | Capital £000 | Total £000 | |
(a) Recognised as distributions in the financial statements for the year | ||||||
Previous year’s final dividend | 896 | 1,791 | 2,687 | – | 2,531 | 2,531 |
Current year’s interim dividend | 442 | 3,318 | 3,760 | 627 | 3,133 | 3,760 |
1,338 | 5,109 | 6,447 | 627 | 5,664 | 6,291 | |
(b) Paid and proposed in respect of the year | ||||||
Interim paid – 1.7p (2024: 1.8p) per share | 442 | 3,318 | 3,760 | 627 | 3,133 | 3,760 |
Final proposed – 1.3p (2024: 1.2p) per share | 660 | 2,198 | 2,858 | 835 | 1,669 | 2,504 |
1,102 | 5,516 | 6,618 | 1,462 | 4,802 | 6,264 |
31 March 2025 £000 | 31 March 2024 £000 | |
Level 1 Quoted venture capital investments | 60 | 358 |
Level 3 Unquoted venture capital investments | 87,829 | 75,421 |
87,889 | 75,779 |
Venture capital – unquoted | Venture capital – quoted | ||
Level 3 £000 | Level 1 £000 | Total £000 | |
Book cost at 31 March 2024 | 76,191 | 441 | 76,632 |
Fair value adjustment at 31 March 2024 | (770) | (83) | (853) |
Fair value at 31 March 2024 | 75,421 | 358 | 75,779 |
Movements in the year: | |||
Purchases at cost | 14,605 | – | 14,605 |
Disposals – proceeds | (10,605) | (376) | (10,981) |
– net realised gains / (losses) on disposal | 3,054 | 94 | 3,148 |
Movements in fair value | 5,354 | (16) | 5,338 |
Fair value at 31 March 2025 | 87,829 | 60 | 87,889 |
Comprising: | |||
Book cost at 31 March 2025 | 82,732 | 218 | 82,950 |
Fair value adjustment at 31 March 2025 | 5,097 | (158) | 4,939 |
87,829 | 60 | 87,889 | |
Equity shares | 69,357 | 60 | 69,417 |
Preference shares | 8,164 | – | 8,164 |
Interest-bearing securities | 10,308 | – | 10,308 |
87,829 | 60 | 87,889 |
Original cost £000 | Carrying value at 31 March 2024 £000 | Disposal proceeds £000 | Realised gain against carrying value £000 | |
Gentronix – disposal of entire holding | 1,164 | 3,689 | 5,181 | 1,492 |
Grip-UK (t/a The Climbing Hangar) – disposal of entire holding | 3,536 | 2,372 | 2,525 | 153 |
Intuitive Holding – disposal of entire holding | 1,508 | 669 | 1,823 | 1,154 |
Pure Pet Food – partial disposal | 133 | 331 | 522 | 191 |
Buoyant Upholstery – partial disposal | 452 | 452 | 452 | – |
musicMagpie – disposal of entire holding | 222 | 282 | 376 | 94 |
Mojo Mortgages – deferred proceeds | – | – | 53 | 53 |
Fresh Approach (UK) Holdings – partial disposal | 38 | 38 | 38 | – |
Evotix – deferred proceeds | – | – | 9 | 9 |
Axial Systems Holdings – deferred proceeds | – | – | 2 | 2 |
Nutshell – in liquidation | 675 | – | – | – |
Ablatus Therapeutics – in liquidation | 559 | – | – | – |
8,287 | 7,833 | 10,981 | 3,148 |
Company | Registered office address | Investment type | Equity £000 | Debt £000 | Total investment cost £000 |
Biological Preparations Group | Unit 12 A-C Pantglas Industrial Estate, Bedwas, Caerphilly CF83 8DR | Unquoted | 561 | 1,605 | 2,166 |
Volumatic Holdings | Taurus House, Endemere Road, Coventry CV6 5PY | Unquoted | 216 | – | 216 |
31 March 2025 £000 | 31 March 2024 £000 | |
Accrued income | 131 | 171 |
Due from investment sales | 2,505 | 708 |
Prepayments | 34 | 32 |
2,670 | 911 |
31 March 2025 £000 | 31 March 2024 £000 | |
Cash at bank | 7,062 | 8,999 |
Money market funds | 31,000 | 34,000 |
38,062 | 42,999 |
31 March 2025 £000 | 31 March 2024 £000 | |
Accruals and deferred income | 543 | 163 |
543 | 163 |
31 March 2025 £000 | 31 March 2024 £000 | |
Allotted and fully paid: | ||
219,852,830 (2024: 208,675,544) ordinary shares of 5.0p | 10,993 | 10,434 |
Share premium £000 | Capital redemption reserve £000 | Capital reserve £000 | Revaluation reserve £000 | Revenue reserve £000 | |
At 31 March 2024 | 52,737 | 1,079 | 54,973 | (853) | 1,156 |
Premium on issue of ordinary shares | 10,361 | – | – | – | – |
Share issue expenses | (465) | – | – | – | – |
Shares purchased for cancellation | – | 389 | (4,211) | – | – |
Realised on disposal of investments | – | – | 3,148 | – | – |
Transfer on disposal of investments | – | – | (454) | 454 | – |
Movements in fair value of investments | – | – | – | 5,338 | – |
Management fee charged to capital net of associated tax | – | – | (1,170) | – | – |
Revenue return aſter tax | – | – | – | – | 1,050 |
Dividends recognised in the year | – | – | (5,109) | – | (1,338) |
At 31 March 2025 | 62,633 | 1,468 | 47,177 | 4,939 | 868 |
Fair value of | Impact: increase* | Impact: decrease* | ||||
As at 31 March 2025 Valuation basis | unquoted investments £000 | Variable input sensitivity | % of net £000* | assets | % of net £000* | assets |
Earnings / revenue multiple | ||||||
Higher sensitivity | 29,448 | +/– 20% | 4,509 | 3.5% | 4,532 | 3.5% |
Lower sensitivity | 33,400 | +/– 10% | 2,219 | 1.7% | 1,797 | 1.4% |
Price of a recent investment subsequently calibrated as appropriate | ||||||
Higher sensitivity | 8,263 | +/– 20% | 698 | 0.5% | 207 | 0.2% |
Lower sensitivity | 16,718 | +/– 10% | 1,323 | 1.0% | 559 | 0.4% |
Total unquoted investments | 87,829 | 8,749 | 6.7% | 7,095 | 5.5% | |
As at 31 March 2024 | ||||||
Valuation basis | ||||||
Earnings / revenue multiple | ||||||
Higher sensitivity | 21,064 | + / – 20% | 3,774 | 3.2% | 3,431 | 2.9% |
Lower sensitivity | 25,058 | + / – 10% | 1,841 | 1.5% | 1,958 | 1.6% |
Price of a recent investment subsequently calibrated as appropriate | ||||||
Higher sensitivity | 13,633 | + / – 20% | 1,534 | 1.3% | 638 | 0.5% |
Lower sensitivity | 15,666 | + / – 10% | 691 | 0.6% | 635 | 0.5% |
Total unquoted investments | 75,421 | 7,840 | 6.6% | 6,662 | 5.5% |
31 March 2025 | 31 March 2024 | |||||
Total fixed rate portfolio £000 | Weighted average interest rate % | Weighted average period for which rate is fixed Years | Total fixed rate portfolio £000 | Weighted average interest rate % | Weighted average period for which rate is fixed Years | |
Fixed rate investments in unquoted companies | 10,308 | 10.4% | 1.8 | 8,928 | 10.4% | 1.4 |
31 March 2025 £000 | 31 March 2024 £000 | |
Floating rate loans to unquoted companies | – | 903 |
Cash and cash equivalents | 38,062 | 42,999 |
38,062 | 43,902 |
31 March 2025 £000 | 31 March 2024 £000 | |
Fixed-rate investments in unquoted companies | 10,575 | 8,928 |
Floating rate loans to unquoted companies | – | 903 |
Cash and cash equivalents | 38,062 | 42,999 |
Accrued dividends and interest receivable | 131 | 171 |
48,768 | 53,001 |